Joachim Müller‐Quernheim

Author

Research Center Borstel - Leibniz Lung Center

Also Known As

J Muller-Quernheim, J Müller-Quernheim, J. Muller-Quernheim, J. MÜLLER-QUERNHEIM, J. Müller-Quernheim, J. MüllerQuernheim, J. Müller‐Quernheim, J. Müller–Quernheim, J. Müller-Quernheim, JOACHIM MÜLLER-QUERNHEIM

427

Publications

16.3K

Citations

H-Index

129

Concepts

All Affiliations

Research Center Borstel - Leibniz Lung Center University Medical Center Freiburg University of Freiburg University of Lübeck Christian-Albrechts-Universität zu Kiel

About

Joachim Müller‐Quernheim is an author at Research Center Borstel - Leibniz Lung Center specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	63	4.8K
2	Health Sciences	7	7	275
3	Public Health	4	4	312
4	Education	1	1	27
5	Engineering	1	1	27

Joachim Müller‐Quernheim

134

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement Robert P. Baughman, Marjolein Drent, Mani S. Kavuru, American Journal of Respiratory and Critical Care Medicine	2006	702
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18 Antje Prasse, Dmitri V. Pechkovsky, Galen B. Toews, American Journal of Respiratory and Critical Care Medicine	2006	488
Sarcoidosis is associated with a truncating splice site mutation in BTNL2 Ruta Valentonyte, Jochen Hampe, Klaus Huse, Nature Genetics Splice Site MutationPathogenesisImmunologyPathologyMedicine	2005	480
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis Nveed Chaudhary, Gerald J. Roth, Frank Hilberg, European Respiratory Journal	2007	387
Toward the blood-borne miRNome of human diseases Andreas Keller, Petra Leidinger, Andrea S. Bauer, Nature Methods Disease MechanismMedicinePathogenesisPathologyBlood-borne Mirnome	2011	360
Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction Dmitri V. Pechkovsky, Antje Prasse, Florian Kollert, Clinical Immunology InflammationFibrosisInflammatory Lung DiseaseLung InflammationCell Signaling	2010	323
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis Antje Prasse, Corinna Probst, Elena Bargagli, American Journal of Respiratory and Critical Care Medicine	2009	322
Common patterns and disease-related signatures in tuberculosis and sarcoidosis Jeroen Maertzdorf, January Weiner, Hans‐Joachim Mollenkopf, Proceedings of the National Academy of Sciences Inflammatory Lung DiseaseImmunologyPathologyImmune SystemInflammation	2012	317
Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis Sylvia Hofmann, André Franke, Annegret Fischer, Nature Genetics Genome-wide Association StudyMolecular Diagnostic TechniquesAutoimmune DiseaseDisease MechanismDisease Etiology	2008	270
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen Joachim Müller‐Quernheim, K Kienast, M Held, European Respiratory Journal RheumatologyAnti-inflammatoryClinical FindingSystemic TreatmentPharmacology	1999	240

Page 1